Chemoinformaics analysis of 1-Propene, 3,3,3-trifluoro-2-methyl-
| Molecular Weight | 110.078 | nRot | 0 |
| Heavy Atom Molecular Weight | 105.038 | nRig | 17 |
| Exact Molecular Weight | 110.034 | nRing | 0 |
| Solubility: LogS | -3.216 | nHRing | 0 |
| Solubility: LogP | 1.423 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 11.685 |
| nHD | 0 | BPOL | 8.35503 |
| QED | 0.701 |
| Synth | 3.447 |
| Natural Product Likeliness | 2.214 |
| NR-PPAR-gamma | 0.17 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.264 |
| HIA | 0.018 |
| CACO-2 | -4.935 |
| MDCK | 0.0000179 |
| BBB | 0.396 |
| PPB | 0.821638 |
| VDSS | 1.086 |
| FU | 0.180361 |
| CYP1A2-inh | 0.208 |
| CYP1A2-sub | 0.604 |
| CYP2c19-inh | 0.067 |
| CYP2c19-sub | 0.514 |
| CYP2c9-inh | 0.062 |
| CYP2c9-sub | 0.776 |
| CYP2d6-inh | 0.059 |
| CYP2d6-sub | 0.427 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.287 |
| CL | 8.876 |
| T12 | 0.433 |
| hERG | 0.014 |
| Ames | 0.118 |
| ROA | 0.306 |
| SkinSen | 0.066 |
| Carcinogencity | 0.919 |
| EI | 0.011 |
| Respiratory | 0.075 |
| NR-Aromatase | 0.647 |
| Antiviral | No |
| Prediction | 0.975309 |